6021-2605 Screening compound: 2,4-BIS(PIPERIDIN-1-YL)QUINAZOLINE

6021-2605 Screening compound: 2,4-BIS(PIPERIDIN-1-YL)QUINAZOLINE
6021-2605 Screening compound: 2,4-BIS(PIPERIDIN-1-YL)QUINAZOLINE alternative view

Chemical Structure Depiction of ChemDiv screening compound 6021-2605
2,4-BIS(PIPERIDIN-1-YL)QUINAZOLINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6021-2605

Molecular Formula

C18H24N4 (C18 H24 N4)

Compound Name

2,4-BIS(PIPERIDIN-1-YL)QUINAZOLINE

IUPAC name

24-bis(piperidin-1-yl)quinazoline

SMILES

C(CC1)CCN1c1nc(N2CCCCC2)nc2ccccc12

InChI

InChI=1S/C18H24N4/c1-5-11-21(12-6-1)17-15-9-3-4-10-16(15)19-18(20-17)22-13-7-2-8-14-22/h3-4,9-10H,1-2,5-8,11-14H2

InChI Key

FBLIPIFFUYCEGY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03079671

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

296.42

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.780

Distribution Coefficient, logD

3.759

Water Solubility, LogSw

-4.91

Polar Surface Area

24.289

Acid Dissociation Constant (pKa)

20.54

Base Dissociation Constant (pKb)

8.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

55.60

6021-2605 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with 6021-2605 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6021-2605?
Check Price and Availability of 6021-2605, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6021-2605 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6021-2605
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6021-2605
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6021-2605 available by request